References
- Alabsi AM, Ali R, Ali AM, et al (2013). Induction of caspase-9, biochemical assessment and morphological changes caused by apoptosis in cancer cells treated with goniothalamin extracted from Goniothalamus macrophyllus. Asian Pac J Cancer Prev, 14, 6273-80. https://doi.org/10.7314/APJCP.2013.14.11.6273
- Arikan SK, Kasap B, Yetimalar H, et al (2014). Impact of prognostic factors on survival rates in patients with ovarian carcinoma. Asian Pac J Cancer Prev, 15, 6087-94. https://doi.org/10.7314/APJCP.2014.15.15.6087
- Dinh P, Harnett P, Piccart-Gebhart MJ, et al (2008). New therapies for ovarian cancer: cytotoxics and molecularly targeted agents. Crit Rev Oncol Hematol, 67, 103-12. https://doi.org/10.1016/j.critrevonc.2008.01.012
- Goff BA, Mandel LS, Drescher CW, et al (2007). Development of an ovarian cancer symptom index: possibilities for earlier detection. Cancer, 109, 221-7. https://doi.org/10.1002/cncr.22371
- Himelstein BP, Canete-Soler R, Bernhard EJ, et al (1994). Metalloproteinases in tumor progression: the contribution of MMP-9. Invasion Metastasis, 14, 246-58.
- Hsu YL, Kuo PL, Lin LT, et al (2005). Isoliquiritigenin inhibits cell proliferation and induces apoptosis in human hepatoma cells. Planta Med, 71, 130-4. https://doi.org/10.1055/s-2005-837779
- Hu X, Li D, Zhang W, et al (2012). Matrix metalloproteinase-9 expression correlates with prognosis and involved in ovarian cancer cell invasion. Arch Gynecol Obstet, 286, 1537-43. https://doi.org/10.1007/s00404-012-2456-6
- Huang M, Xu Q, Deng XX (2014). l-Ascorbic acid metabolism during fruit development in an ascorbate-rich fruit crop chestnut rose (Rosa roxburghii Tratt). J Plant Physiol, 171, 1205-16. https://doi.org/10.1016/j.jplph.2014.03.010
- Jemal A, Siegel R, Ward E, et al (2008). Cancer statistics, 2008. CA Cancer J Clin, 58, 71-96. https://doi.org/10.3322/CA.2007.0010
- Kanazawa M, Satomi Y, Mizutani Y, et al (2003). Isoliquiritigenin inhibits the growth of prostate cancer. Eur Urol, 43, 580-6. https://doi.org/10.1016/S0302-2838(03)00090-3
- Kessenbrock K, Plaks V, Werb Z (2010). Matrix metalloproteinases: regulators of the tumor microenvironment. Cell, 141, 52-67. https://doi.org/10.1016/j.cell.2010.03.015
- Li LN, Zhou X, Gu Y, et al (2013). Prognostic value of MMP-9 in ovarian cancer: a meta-analysis. Asian Pac J Cancer Prev, 14, 4107-13. https://doi.org/10.7314/APJCP.2013.14.7.4107
- Liotta LA, Stetler-Stevenson WG (1990). Metalloproteinases and cancer invasion. Semin Cancer Biol, 1, 99-106.
- Liu W, Li SY, Huang XE, et al (2012). Inhibition of tumor growth in vitro by a combination of extracts from Rosa roxburghii Tratt and Fagopyrum cymosum. Asian Pac J Cancer Prev, 13, 2409-14. https://doi.org/10.7314/APJCP.2012.13.5.2409
- Ma YX, Zhu Y, Wang CF, et al (1997). The aging retarding effect of 'Long-Life CiLi'. Mech Ageing Dev, 96, 171-80. https://doi.org/10.1016/S0047-6374(97)01890-3
- Parmo-Cabanas M, Molina-Ortiz I, Matias-Roman S, et al (2006). Role of metalloproteinases MMP-9 and MT1-MMP in CXCL12-promoted myeloma cell invasion across basement membranes. J Pathol, 208, 108-18. https://doi.org/10.1002/path.1876
- Sengupta A, Ghosh S, Das S (2001). Modulation of DMBA induced genotoxicity in bone marrow by quercetin during skin carcinogenesis. J Exp Clin Cancer Res, 20, 131-4.
- Shan Z, Feng-Nian R, Jie G, et al (2012). Effects of valproic acid on proliferation, apoptosis, angiogenesis and metastasis of ovarian cancer in vitro and in vivo. Asian Pac J Cancer Prev, 13, 3977-82. https://doi.org/10.7314/APJCP.2012.13.8.3977
- Siegel R, Ma J, Zou Z, et al (2014). Cancer statistics, 2014. CA Cancer J Clin, 64, 9-29. https://doi.org/10.3322/caac.21208
- Stallings-Mann M, Radisky D (2007). Matrix metalloproteinaseinduced malignancy in mammary epithelial cells. Cells Tissues Organs, 185, 104-10. https://doi.org/10.1159/000101310
- Sun ZL, Tang YJ, Wu WG, et al (2013). AZD1480 can inhibit the biological behavior of ovarian cancer SKOV3 cells in vitro. Asian Pac J Cancer Prev, 14, 4823-7. https://doi.org/10.7314/APJCP.2013.14.8.4823
- Vaughan S, Coward JI, Bast RC, et al (2011). Rethinking ovarian cancer: recommendations for improving outcomes. Nat Rev Cancer, 11, 719-25. https://doi.org/10.1038/nrc3144
- Yang X, Lv Y, Tian L, et al (2010). Composition and systemic immune activity of the polysaccharides from an herbal tea (Lycopus lucidus Turcz). J Agric Food Chem, 58, 6075-80. https://doi.org/10.1021/jf101061y
- Zhang C, Liu X, Qiang H, et al (2001). Inhibitory effects of Rosa roxburghii tratt juice on in vitro oxidative modification of low density lipoprotein and on the macrophage growth and cellular cholesteryl ester accumulation induced by oxidized low density lipoprotein. Clin Chim Acta, 313, 37-43. https://doi.org/10.1016/S0009-8981(01)00647-7
Cited by
- Targeting of Topoisomerase I for Prognoses and Therapeutics of Camptothecin-Resistant Ovarian Cancer vol.10, pp.7, 2015, https://doi.org/10.1371/journal.pone.0132579
- Chemical Analysis of Dietary Constituents in Rosa roxburghii and Rosa sterilis Fruits vol.21, pp.9, 2016, https://doi.org/10.3390/molecules21091204
- Therapeutic Applications of Rose Hips from Different Rosa Species vol.18, pp.6, 2017, https://doi.org/10.3390/ijms18061137
- Ultrasound-assisted extraction, characterization, and antioxidant activity in vitro and in vivo of polysaccharides from Chestnut rose (Rosa roxburghii tratt) fruit vol.55, pp.3, 2018, https://doi.org/10.1007/s13197-017-3023-8
- Tratt fruit and its α-glucosidase inhibitory activity vol.9, pp.7, 2018, https://doi.org/10.1039/C8FO00561C